HomeOpen Access NewsEuropean Commission

European Commission

EU commission launches public consultation on EU ETS and MSR

The European Commission has revealed a new wide-ranging public consultation on the EU Emissions Trading System (EU ETS) and its Market Stability Reserve (MSR). It hopes to get feedback before planned reviews in 2026.

European Commission to create “transparency mechanism” for vaccine exports

In response to the AstraZeneca feud, EU officials are creating a "transparency mechanism" for vaccine exports - which would indirectly hold companies accountable for fulfilling their agreed contracts.

European Commission launches new Green Consumption Pledge

The European Commission has launched its new Green Consumption Pledge, the first initiative delivered under the New Consumer Agenda.

European Commission will get 60% less AstraZeneca vaccines

EU leaders are investigating why AstraZeneca are not following through with the pre-agreed number of vaccines for the Member States - taking a 60% cut to the expected amount.

European Commission outlines key actions to beat COVID-19

The European Commission has set out the key actions needed to step up the fight against the COVID-19 pandemic.

Why energy is at the heart of the EU’s decarbonisation efforts

Kadri Simson, EU Energy Commissioner, discusses why the EU has placed energy and the heart of its decarbonisation efforts.

EU finalises talks with Valneva to secure a new vaccine

Today, the European Commission concluded talks with Valneva to secure a new potential vaccine against COVID-19.

European Commission gives 24 grants to COVID-19 plasma projects

The projects will happen in 14 Member States and the United Kingdom, with 36 million in funding to get COVID-19 plasma to patients - boosting their immune response to the virus.

EU to purchase further 300 million doses of BioNTech-Pfizer vaccine

The European Commission has proposed to purchase an additional 300 million doses of the COVID-19 vaccine produced by BioNTech and Pfizer.

Moderna vaccine approved for use by European Medicines Agency

The EMA joins the US in approving the 94.1% effective Moderna vaccine for use, while the UK still waits on further regulatory discussions.

Renewables, hydrogen and ocean energy in Europe

The European Commission’s energy policy ambitions are charted here by Open Access Government, including developments in clean energy, renewables, hydrogen and ocean energy.

Europe’s green road to recovery

Mauro Petriccione, Directorate-General for Climate Action at the European Commission, illustrates Europe’s plans for a green recovery following the COVID-19 pandemic.

British company launches fast-acting antimicrobial coating that destroys coronavirus

Here, we learn about a British company launching a fast-acting antimicrobial coating that destroys coronavirus.

How can Europe protect migrants with disabilities and mental health problems?

Mental Health Europe point out that the New Pact on Migration and Asylum leaves behind migrants with disabilities and mental health problems, suggesting how this oversight could be resolved.

How is extensive research informing EU policy-making?

Megan Warrender, Assistant Editor at Open Access Government, investigates the current and future policy priorities of the Commissioner for the Environment, Oceans and Fisheries, Virginijus Sinkevičius, and what is influencing them.

Independent FDA Committee says Pfizer vaccine is ready for the US

The independent experts of the FDA say the Pfizer vaccine is good to go, which means that the COVID vaccine should be formally approved in a matter of days.

Project SPROUT: The new urban blueprint for sustainable mobility

We spoke with Dr Teresa de la Cruz, Project Manager at Zaragoza Logistics Center and Dr Georgia Ayfantopoulou, Research Director, Deputy Director Hellenic Institute of Transport, Centre for Research and Technology Hellas, about their work to create a universal set of policies for sustainable mobility.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders